Differential release of mast cell mediators and the pathogenesis of inflammation

Immunological Reviews

Volumn 217, Issue 1, 2007, Pages 65-78

  Theoharides, Theoharis C ^a,b   Kempuraj, Duraisamy ^a   Tagen, Michael ^a   Conti, Pio ^c   Kalogeromitros, Dimitris ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Brain; Inflammation; Mast cells; Multiple sclerosis; Stress; Vascular permeability

Indexed keywords

BACTERIAL ANTIGEN; CHONDROITIN SULFATE; CORTICOTROPIN RELEASING FACTOR; CROMOGLYCATE DISODIUM; CYTOKINE; FLAVONOID; GROWTH FACTOR; HORMONE; INTERLEUKIN 6; PROTEIN KINASE C; QUERCETIN; RANTES; TOLL LIKE RECEPTOR; VASCULOTROPIN; VIRUS ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ALLERGIC REACTION; ANAPHYLAXIS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL TYPE; CEREBROSPINAL FLUID; DEMYELINATING DISEASE; ENCEPHALOMYELITIS; ENZYME PHOSPHORYLATION; EXOCYTOSIS; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAST CELL; MAST CELL DEGRANULATION; MICROSCOPY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SECRETORY VESICLE; SIGNAL TRANSDUCTION; STRESS; SYNAPTIC TRANSMISSION; UPREGULATION;

BIOGENIC MONOAMINES; ENZYMES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS; MULTIPLE SCLEROSIS; PEPTIDES;

EID: 34248137929     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00519.x     Document Type: Review

References (194)

1. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996 271 : 818 822.
2. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 2005 102 : 11408 11413.
3. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005 6 : 135 142.
4. Valent P, et al. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 2001 179 : 74 81.
5. Juremalm M, Nilsson G. Chemokine receptor expression by mast cells. Chem Immunol Allergy 2005 87 : 130 144.
6. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977 133 : 358 366.
7. Conti P, et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 1997 89 : 4120 4127.
8. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 2004 25 : 266 273.
9. Grutzkau A, et al. Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998 9 : 875 884.
10. Boesiger J, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J Exp Med 1998 188 : 1135 1145.
11. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004 104 : 2410 2417.
12. Ochi H, DeJesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci USA 2000 97 : 10509 10513.
13. Lorentz A, et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005 174 : 6751 6756.
14. Bischoff SC, Sellge G, Manns MP, Lorentz A. Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int Arch Allergy Immunol 2001 124 : 151 154.
15. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004 146 : 1 12.
16. Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a. Clin Immunol 2004 110 : 172 180.
17. Cruse G, Kaur D, Yang W, Duffy SM, Brightling CE, Bradding P. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005 25 : 858 863.
18. Kraneveld AD, et al. Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci USA 2005 102 : 1578 1583.
19. Redegeld FA, et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002 8 : 694 701.
20. Redegeld FA, Nijkamp FP. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol 2003 24 : 181 185.
21. van Ophoven A, Hertle L. Long-term results of amitriptyline treatment for interstitial cystitis. J Urol 2005 174 : 1837 1840.
22. Rottem M, Mekori YA. Mast cells and autoimmunity. Autoimmun Rev 2005 4 : 21 27.
23. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005 23 : 749 786.
24. Maurer M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004 432 : 512 516.
25. Norrby K. Mast cells and angiogenesis. APMIS 2002 110 : 355 371.
26. Theoharides TC, Conti P. Mast cells: the JEKYLL and HYDE of tumor growth. Trends Immunol 2004 25 : 235 241.
27. Ribatti D, Crivellato E, Roccaro AM, Ria R, Vacca A. Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 2004 34 : 1660 1664.
28. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res 2003 92 : 485 492.
29. Ribatti D, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 2005 193 : 1961 1965.
30. Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC. Definitive characterization of rat hypothalamic mast cells. Neuroscience 1996 73 : 889 902.
31. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002 420 : 875 878.
32. Woolley DE. The mast cell in inflammatory arthritis. N Engl J Med 2003 348 : 1709 1711.
33. Theoharides TC, Bondy PK, Tsakalos ND, Askenase PW. Differential release of serotonin and histamine from mast cells. Nature 1982 297 : 229 231.
34. Kops SK, Theoharides TC, Cronin CT, Kashgarian MG, Askenase PW. Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res 1990 262 : 415 424.
35. Kops SK, Van Loveren H, Rosenstein RW, Ptak W, Askenase PW. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell derived antigen-binding factor. Lab Invest 1984 50 : 421 434.
36. Theoharides TC, Douglas WW. Secretion in mast cells induced by calcium entrapped within phospholipid vesicles. Science 1978 201 : 1143 1145.
37. Van Loveren H, Kops SK, Askenase PW. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur J Immunol 1984 14 : 40 47.
38. Benyon R, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989 97 : 898 904.
39. Levi-Schaffer F, Shalit M. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. Int Arch Allergy Appl Immunol 1989 90 : 352 357.
40. van Haaster CM, Engels W, Lemmens PJMR, Hornstra G, van der Vusse GJ, Heemskerk JWM. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells: roles of cytosolic calcium and protein tyrosine kinases. Biochim Biophys Acta 1995 1265 : 79 88.
41. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994 152 : 5468 5476.
42. Marquardt DL, Alongi JL, Walker LL. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J Immunol 1996 156 : 1942 1945.
43. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood 1997 89 : 2654 2663.
44. Hojo H, et al. Differential production of interleukin-6 and its close relation to liver metastasis in clones from murine P815 mastocytoma. Cancer Lett 1996 108 : 55 59.
45. Kandere-Grzybowska K, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 2003 171 : 4830 4836.
46. Cao J, Curtis CL, Theoharides TC. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol 2006 69 : 998 1006.
47. Abdel-Majid RM, Marshall JS. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol 2004 172 : 1227 1236.
48. Nakayama T, Mutsuga N, Yao L, Tosato G. Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J Leukoc Biol 2006 79 : 95 104.
49. Kay LJ, Yeo WW, Peachell PT. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol 2006 147 : 707 713.
50. Nguyen M, Pace AJ, Koller BH. Age-induced reprogramming of mast cell degranulation. J Immunol 2005 175 : 5701 5707.
51. Lin TJ, Issekutz TB, Marshall JS. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol 2000 165 : 211 220.
52. Fischer M, et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006 116 : 2748 2756.
53. Gomez G, et al. Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol 2005 175 : 7602 7610.
54. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001 2 : 675 680.
55. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000 406 : 782 787.
56. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003 130 : 180 192.
57. Varadaradjalou S, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003 33 : 899 906.
58. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003 170 : 1625 1629.
59. Masuda A, Yoshikai Y, Aiba K, Matsuguchi T. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J Immunol 2002 169 : 3801 3810.
60. Supajatura V, et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002 109 : 1351 1359.
61. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006 107 : 610 618.
62. Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004 173 : 531 541.
63. Ikeda RK, et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol 2003 171 : 4860 4867.
64. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004 114 : 174 182.
65. Hyde BB, Papadopoulou N, Theoharides TC. Human mast cells express TLR 3, 7&9, mRNA is induced by viral DNA sequence K3 CPG-ODN. Proc Am Assoc Immunol 2006 (Boston May 12-16 176 : 5322.
66. Xiao W, et al. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J Immunol 2005 175 : 6885 6892.
67. Odom S, et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004 199 : 1491 1502.
68. Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005 138 : 29 39.
69. Oka T, Hori M, Tanaka A, Matsuda H, Karaki H, Ozaki H. IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Am J Physiol Cell Physiol 2004 286 : C256 C263.
70. Gonzalez-Espinosa C, et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med 2003 197 : 1453 1465.
71. Triggiani M, et al. Differential modulation of mediator release from human basophils and mast cells by mizolastine. Clin Exp Allergy 2004 34 : 241 249.
72. Stassen M, et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 2001 166 : 4391 4398.
73. Tachimoto H, et al. Reciprocal regulation of cultured human mast cell cytokine production by IL-4 and IFN-γ. J Allergy Clin Immunol 2000 106 : 141 149.
74. Klemm S, et al. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J Exp Med 2006 203 : 337 347.
75. Nishida K, et al. Fc{epsilon}RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 2005 170 : 115 126.
76. Hepp R, Puri N, Hohenstein AC, Crawford GL, Whiteheart SW, Roche PA. Phosphorylation of SNAP-23 regulates exocytosis from mast cells. J Biol Chem 2005 280 : 6610 6620.
77. Dimitriadou V, Lambracht-Hall M, Reichler J, Theoharides TC. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience 1990 39 : 209 224.
78. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience 1991 44 : 97 112.
79. Theoharides TC, Sant GR, El-Mansoury M, Letourneau RJ, Ucci AA Jr., Meares EM Jr. Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J Urol 1995 153 : 629 636.
80. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996 77 : 41 54.
81. Dvorak AM, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 1992 99 : 74 83.
82. Dvorak AM. Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. Chem Immunol Allergy 2005 85 : 252 315.
83. Tamir H, Theoharides TC, Gershon MD, Askenase PW. Serotonin storage pools in basophil leukemia and mast cells: characterization of two types of serotonin binding protein and radioautographic analysis of the intracellular distribution of [3H] serotonin. J Cell Biol 1982 93 : 638 647.
84. Spencer LA, Melo RC, Perez SA, Bafford SP, Dvorak AM, Weller PF. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci USA 2006 103 : 3333 3338.
85. Lessmann E, Leitges M, Huber M. A redundant role for PKC-epsilon in mast cell signaling and effector function. Int Immunol 2006 18 : 767 773.
86. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006 117 : 1214 1225.
87. Furumoto Y, et al. Cutting edge: lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol 2006 176 : 5167 5171.
88. Stempelj M, Ferjan I. Signaling pathway in nerve growth factor induced histamine release from rat mast cells. Inflamm Res 2005 54 : 344 349.
89. Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol 2006 148 : 208 215.
90. Rivera J. Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation. Trends Immunol 2006 27 : 251 253.
91. Jayapal M, et al. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 2006 7 : 210.
92. Rodriquez M. Multiple sclerosis: insights into molecular pathogenesis and therapy. Mayo Clin Proc 1997 72 : 663 664.
93. Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999 1390 : 1649 1673.
94. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994 53 : 328 337.
95. McFarland HF. Complexities in the treatment of autoimmune disease. Science 1996 274 : 2037 2038.
96. Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol 2004 25 : 132 137.
97. Robbie-Ryan M, Tanzola MB, Secor VH, Brown MA. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 2003 170 : 1630 1634.
98. Pedotti R, De Voss JJ, Steinman L, Galli SJ. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 2003 24 : 479 484.
99. Pedotti R, et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc Natl Acad Sci USA 2003 100 : 1867 1872.
100. Theoharides TC, Dimitriadou V, Letourneau RJ, Rozniecki JJ, Vliagoftis H, Boucher WS. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: changes resembling early stages of demyelination. Neuroscience 1993 57 : 861 871.
101. Griffin DE, Mendoza QP. Identification of the inflammatory cells present in the central nervous system of normal and mast cell-deficient mice during Sindbis virus encephalitis. Cell Immunol 1986 97 : 454 459.
102. Mokhtarian F, Griffin DE. The role of mast cells in virus-induced inflammation in the murine central nervous system. Cell Immunol 1984 86 : 491 500.
103. Secor VH, Secor WE, Gutekunst C-A, Brown MA. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000 191 : 813 821.
104. Robbie-Ryan M, Brown M. The role of mast cells in allergy and autoimmunity. Curr Opin Immunol 2002 14 : 728 733.
105. Brown MA, Tanzola M, Robbie-Ryan M. Mechanisms underlying mast cell influence on EAE disease course. Mol Immunol 2002 38 : 1373 1378.
106. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 2001 167 : 4008 4016.
107. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005 102 : 6467 6472.
108. Kempuraj D, et al. Myelin basic protein stimulates human mast cells and together they activate T cells: inhibition by luteolin and implications for multiple sclerosis. Proc Keystone Symposia. Mast cells, basophils and Igb: Host defenses and diseases (Jan 20-24, 2007). Copper Mountain, CO : 52.
109. Mohr DC, et al. Psychological stress and the subsequent appearances of new brain MRI lesions in MS. Neurology 2000 55 : 55 61.
110. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 1974 50 : 611 618.
111. Krüger PG, et al. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol Scand 1990 81 : 31 36.
112. Kermode AG, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 1990 113 : 1477 1489.
113. Lock C, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002 8 : 500 508.
114. Bomprezzi R, et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003 12 : 2191 2199.
115. De Jager PL, Hafler DA. Gene expression profiling in MS: what is the clinical relevance? Lancet Neurol 2004 3 : 269.
116. Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995 37 : 63 66.
117. Malamud V, et al. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis. J Neuoimmunol 2003 138 : 115 122.
118. Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost 2006 32 (Suppl 39 48.
119. Steinhoff M, et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005 26 : 1 43.
120. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004 84 : 579 621.
121. Greenfeder S, et al. Tryptase-induced airway microvascular leakage in guinea pigs: involvement of tachykinins and leukotrienes. Eur J Pharmacol 2004 419 : 261 267.
122. De Vreis HE, Kuiper J, de Boer AG, Van Berkel TJC, Breimer DD. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997 49 : 143 155.
123. Moor ACE, de Vries HE, de Boer AG, Breimer DD. The blood-brain barrier and multiple sclerosis. Biochem Pharmacol 1994 47 : 1717 1724.
124. Kwon EE, Prineas JW. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994 53 : 625 636.
125. Syndulko K, Tourtellotte WW, Conrad AJ, Izuierdo G, Multiple Sclerosis Study Group, Alpha Interferon Study Group. Trans-blood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients. J Neuroimmunol 1993 46 : 185 192.
126. Theoharides TC. Mast cells: the immune gate to the brain. Life Sci 1990 46 : 607 617.
127. Letourneau R, Rozniecki JJ, Dimitriadou V, Theoharides TC. Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis. J Neuroimmunol 2003 145 : 18 26.
128. Lambracht-Hall M, Dimitriadou V, Theoharides TC. Migration of mast cells in the developing rat brain. Dev Brain Res 1990 56 : 151 159.
129. Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood to brain. J Neurosci 2000 20 : 401 408.
130. Wilhelm M, Silver R, Silverman AJ. Central nervous system neurons acquire mast cell products via transgranulation. Eur J Neurosci 2005 22 : 2238 2248.
131. Theoharides TC, Konstantinidou A. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007 12 : 1615 1628.
132. Theoharides TC, et al. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 1995 136 : 5745 5750.
133. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, Pang X, Theoharides TC. Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res 1999 849 : 1 15.
134. Esposito P, et al. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002 303 : 1061 1066.
135. Esposito P, et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 2001 888 : 117 127.
136. Chandler N, Jacobson S, Connolly R, Esposito P, Theoharides TC. Acute stress shortens the time of onset of experimental allergic encephalomyelitis (EAE) in SJL/J mice. Brain Behav Immun 2002 16 : 757 763.
137. Benou C, et al. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 2005 174 : 5407 5413.
138. Campbell T, et al. The effects of restraint stress on the neuropathogenesis of Theiler's virus infection: I. Acute disease. Brain Behav Immun 2001 15 : 235 254.
139. Sieve AN, et al. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J Neuroimmunol 2004 155 : 103 118.
140. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999 13 : 225 239.
141. Theoharides TC, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998 139 : 403 413.
142. Singh LK, et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmacol Exp Ther 1999 288 : 1349 1356.
143. Clifton VL, Crompton R, Smith R, Wright IM. Microvascular effects of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab 2002 87 : 267 270.
144. Cao J, et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005 174 : 7665 7675.
145. Brown RF, Tennant CC, Dunn SM, Pollard JD. A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005 11 : 477 484.
146. Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress. Neurology 1999 52 : 1737 1745.
147. Warren S, Greenhill S, Warren KG. Emotional stress and the development of multiple sclerosis: case control evidence of a relationship. J Chronic Dis 1982 35 : 821 831.
148. Mei-Tal V, Meyerowitz S, Engel GL. The role of psychological process in a somatic disorder: multiple sclerosis. 1. The emotional setting of illness onset and exacerbation. Psychosom Med 1970 32 : 67 86.
149. Ackerman KD, et al. Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun 2003 17 : 141 151.
150. Buljevac D, et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003 327 : 646.
151. Li J, Johansen C, Bronnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The risk of multiple sclerosis in bereaved parents: a nationwide cohort study in Denmark. Neurology 2004 62 : 726 729.
152. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004 328 : 731.
153. Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005 26 : 644 652.
154. Heesen C, Schulz H, Schmidt M, Gold S, Tessmer W, Schulz KH. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun 2002 16 : 282 287.
155. Huang M, Pang X, Karalis K, Theoharides TC. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc Res 2003 59 : 241 249.
156. Lalive PH, Burkhard PR, Chofflon M. TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse. Behav Neurosci 2002 116 : 1093 1097.
157. Fox RJ, Ransohoff RM. New directions in MS therapeutics: vehicles of hope. Trends Immunol 2004 25 : 632 636.
158. Zappulla JP, Arock M, Mars LT, Liblau RS. Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol 2002 131 : 5 20.
159. Shin HY, Kim JS, An NH, Park RK, Kim HM. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci 2004 74 : 2877 2887.
160. Theoharides TC, Sieghart W, Greengard P, Douglas WW. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 1980 207 : 80 82.
161. Theoharides TC, et al. Chondroitin sulfate inhibits connective tissue mast cells. Br J Pharmacol 2000 131 : 1039 1049.
162. Middleton E Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000 52 : 673 751.
163. Kempuraj D, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 2005 145 : 934 944.
164. Shichijo M, Yamamoto N, Tsujishita H, Kimata M, Nagai H, Kokubo T. Inhibition of syk activity and degranulation of human mast cells by flavonoids. Biol Pharm Bull 2003 26 : 1685 1690.
165. Sieghart W, Theoharides TC, Douglas WW, Greengard P. Phosphorylation of a single mast cell protein in response to drugs that inhibit secretion. Biochem Pharmacol 1981 30 : 2737 2738.
166. Correia I, Wang L, Pang X, Theoharides TC. Characterization of the 78 kDa mast cell protein phosphorylated by the antiallergic drug cromolyn and homology to moesin. Biochem Pharmacol 1996 52 : 413 424.
167. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 2005 175 : 7989 7995.
168. Cherwinski HM, et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J Immunol 2005 174 : 1348 1356.
169. Andrasfalvy M, et al. The beta subunit of the type I Fcepsilon receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells. J Immunol 2005 175 : 2801 2806.
170. Forssell J, et al. Interleukin-2-inducible T cell kinase regulates mast cell degranulation and acute allergic responses. Am J Respir Cell Mol Biol 2005 32 : 511 520.
171. Davis BJ, Flanagan BF, Gilfillan AM, Metcalfe DD, Coleman JW. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J Immunol 2004 173 : 6914 6920.
172. Hendriks JJ, de Vries HE, van der Pol SM, van den Berg TK, van Tol EA, Dijkstra CD. Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem Pharmacol 2003 65 : 877 885.
173. Aktas O, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol 2004 173 : 5794 5800.
174. Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 2004 200 : 1667 1672.
175. Verbeek R, Plomp AC, van Tol EA, van Noort JM. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol 2004 68 : 621 629.
176. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004 25 : 563 568.
177. Theoharides TC, Kalogeromitros D. The critical role of mast cell in allergy and inflammation. Ann NY Acad Sci 2006 1088 : 78 99.
178. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006 27 : 32 39.
179. Theoharides TC, Papaliodis D, Tagen M, Konstantinidou A, Kempuraj D, Clemons A. Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol 2005 25 : 515 520.
180. Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia - new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006 19 : 5 10.
181. Theoharides TC. Synovial mast cells in inflammatory arthritis. In : Meyers ED, ed. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Larkspur, CA : Ramtech Ltd., 2005 : 37 63.
182. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001 57 : 47 55.
183. Theoharides T, Sant GR. Immunomodulators for the treatment of interstitial cystitis. Urology 2005 65 : 633 638.
184. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Rev 2005 49 : 65 76.
185. Lin TJ, Hirji N, Nohara O, Stenton GR, Gilchrist M, Befus AD. Mast cells express novel CD8 molecules that selectively modulate mediator secretion. J Immunol 1998 161 : 6265 6272.
186. Papadopoulou NG, Oleson L, Kempuraj D, Donelan J, Cetrulo CL, Theoharides TC. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J Mol Endocrinol 2005 35 : R1 R8.
187. Coulombe M, Battistini B, Stankova J, Pouliot P, Bissonnette EY. Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines. J Leukoc Biol 2002 71 : 829 836.
188. Hogaboam CM, Befus AD, Wallace JL. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993 151 : 3767 3774.
189. Gupta AA, Leal-Berumen I, Croitoru K, Marshall JS. Rat peritoneal mast cells produce IFN-y following IL-12 treatment but not in response to IgE-mediated activation. J Immunol 1996 157 : 2123 2128.
190. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002 195 : 583 592.
191. Kalesnikoff J, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001 14 : 801 811.
192. Leal-Berumen I, O'Byrne P, Gupta A, Richards CD, Marshall JS. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 1995 154 : 4759 4767.
193. Gordon JR, Zhang X, Stevenson K, Cosford K. Thrombin induces IL-6 but not TNF-α secretion by mouse mast cells: threshold-level thrombin receptor and very low level FcεRI signaling synergistically enhance IL-6 secretion. Cell Immunol 2000 205 : 128 135.
194. Leal-Berumen I, Snider DP, Barajas-Lopez C, Marshall JS. Cholera toxin increases IL-6 synthesis and decreases TNF-α production by rat peritoneal mast cells. J Immunol 1996 156 : 316 321.